Enabling more convenient STI testing
- For those coming to the clinic we offer CT/NG testing via our FDA-cleared point-of-care system
- For those wanting screening from the convenience of home, we offer at-home sample collection for testing at our partner reference laboratories
binx revolutionizes STI diagnostics with a suite of technology solutions that radically improve the patient and clinician experience.
Together we can take on the STI epidemic. With convenient, discreet, and efficient testing, binx eliminates the largest barriers to stopping the spread of infection.
binx empowers your staff to provide superior STI care.
At-home: binx at-home, clinician-mediated testing is convenient and discreet. Patients collect samples, send to our partner reference laboratories, and receive results from the comfort of their home, eliminating barriers to testing such as stigma and inconvenience.
At the point-of-care: binx io is the world’s first FDA-cleared and CLIA-waved, molecular point-of-care test providing central lab quality results in about 30 minutes for chlamydia and gonorrhea in women and men.
Online: binx connect puts the control in the clinicians hands, letting clinicians order binx at-home collection for patients, view data about local populations, and make strategic decisions about how to reach untested members of the local community.
Used together or separately, binx technology solutions help you increase screening rates, improve health outcomes, and limit the spread of STIs.
Want to know more?
Join us in helping to improve the sexual health of your patients.